Home > Press > Patent for Coaxial Nanofibre Production: Scientists from Contipro have patented new jet for effective coaxial nanofibers production
Abstract:
Although nanofibres are thousands of times finer than a human hair, with current technology scientists can produce fibres of this size where the inside is made with a different material from the outer coating. However, this success has mainly been limited to laboratory, as the switch to full-scale production has proved to be a very difficult technical problem.
Contipro's scientists have now managed to overcome the obstacles hampering the industrial production of coaxial nanofibres. To increase the production of coaxial fibres, they have developed a jet, the patent for which has been published this month. The invention's European creators expect this to result in particular in the possibility of transferring the preparation of coaxial fibres from the laboratory to genuinely industrial-scale production. The advantage of the jet, besides the amount it can produce, is that it is easy to clean and maintain.
Coaxial fibres can potentially be used for a number of interesting applications. The fibre coating, for example, can be made from quickly soluble material which releases a large amount of substance from the huge surface of nanofibres in a short time. Conversely, the middle of a fibre can retain its mechanical properties and release only small quantities of substance over an extended period. The correct timing can be controlled for all of these processes. A particular application could be for the decoupling materials used in operations of the abdominal cavity. Over the space of a few days, a substance is released from the fibre coating that prevents inflammation. Then, after two weeks of healing, the fibre core releases an agent promoting tissue regeneration. After two weeks, the material, having prevented unwanted accretions and accelerated the healing process, is completely dissolved.
A device 4SPIN introduced by the same group of developers in Japan at the start of the year is to focus on these new applications. This device, approximately a metre in height, facilitates laboratory research and the development of nano-materials for tissue engineering and other fields unrelated to medicine. According to its creators, the device's main advantage is its emphasis on processing difficult-to-spin polymers and the possibility of almost perfectly aligning nanofibres.
####
About Contipro Biotech
Contipro Biotech is an innovative company from the Czech Republic primarily focusing on bio and nanotechnology. Its laboratory apparatus 4SPIN is able to process a wide range of natural and synthetic polymers with highly repeatable results. Due to its modular character and friendly user interface, many crucial properties such as fiber alignment, diameter or fiber density can be easily controlled and optimized. Contipro can offer scientific support for processing of biopolymers, as well as the materials used for nanoapplications in medicine. There are more than 90 researchers employed in company's R&D laboratories and research is backed by twenty years of experience. Contipro is a world leading company in hyaluronan chemistry.
For more information, please click here
Contacts:
Tomas Papez
Contipro Group
(420) 606 747 097
Copyright © Contipro Biotech
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||